MEDP logo

Medpace Holdings Inc. (MEDP)

$648.20

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MEDP

Market cap

$18.13B

EPS

18.02

P/E ratio

35.8

Price to sales

6.14

Dividend yield

--

Beta

1.122834

Price on MEDP

Previous close

$653.94

Today's open

$653.94

Day's range

$644.30 - $656.56

52 week range

$373 - $693.97

Profile about MEDP

CEO

August J. Troendle

Employees

5900

Headquarters

Cincinnati, OH

Exchange

Nasdaq Global Select

Shares outstanding

27971686

Issue type

Common Stock

MEDP industries and sectors

Healthcare

Biotechnology & Life Sciences

News on MEDP

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

Here is how Medpace (MEDP) and Atea Pharmaceuticals, Inc. (AVIR) have performed compared to their sector so far this year.

news source

Zacks Investment Research • Nov 13, 2026

news preview

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Madison Mid Cap Fund Q3 2026 Portfolio Activity

The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvity, and Waters Corporation. The bottom five detractors for the quarter were MKS, Floor & Decor Holdings, Carlisle Companies, Moelis and Co., and Glacier Bancorp.

news source

Seeking Alpha • Nov 6, 2026

news preview

CON vs. MEDP: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

news source

Zacks Investment Research • Nov 2, 2026

news preview

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Oct 30, 2026

news preview

Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

news source

Zacks Investment Research • Oct 29, 2026

news preview

Here's Why Medpace (MEDP) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Oct 26, 2026

news preview

All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy

Medpace (MEDP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Oct 26, 2026

news preview

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

news source

Zacks Investment Research • Oct 26, 2026

news preview

Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate

Medpace Holdings is downgraded from "Buy" to "Hold" due to decelerating growth metrics and underwhelming forward guidance. Q3 2026 Net New Business Awards rose just 10.6%, a sharp slowdown from Q2's 28.2% growth, signaling weaker contract momentum. Revenue growth in Q3 2026 was 8.5% to $716M, below the prior quarter's 17.2% pace and only modestly above consensus.

news source

Seeking Alpha • Oct 25, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Medpace Holdings Inc.

Open an M1 investment account to buy and sell Medpace Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MEDP on M1